Trial
NCT05747794
Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in Combination With Paclitaxel Chemotherapy
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Immutep S.A.S.
Collaborators
—
Condition
Breast Carcinoma
Intervention
eftilagimod alpha
Why stopped
Sponsor Decision
Provenance
Dataset: 2026-07-31 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-30